RxDoctor Payments Data
★ My doctorsLook up a doctor →

Randall Ow

Otolaryngology · Roseville, CANPI 1336142009

Payments from drug & device makers

What this record shows

This record is dominated by speaking fees: $369,026 of the $612,640 with a category attached, or 60.2%. 27 manufacturers reported payments, led by Regeneron Healthcare Solutions, Inc. at 35.3% of the total. Among otolaryngology clinicians in CA with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$612,640in general payments, 2019–2025

Across 868 payments — averaging $705.81 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Regeneron Healthcare Solutions, Inc.$216K
  • Optinose US, Inc.$105K
  • GSK$94K
  • Aerin Medical Inc.$49K
  • Sanofi$47K
  • Stryker$39K
  • plus $63K from 21 others
$4,411,104in research payments, 2019–2025

Across 749 payments — averaging $5889.32 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Optinose US, Inc.$755K
  • Aerin Medical Inc.$526K
  • Neurent Medical Limited$462K
  • Livanova USA, Inc.$449K
  • Sanofi US Services Inc.$423K
  • GSK$377K
  • plus $1.4M from 16 others

What the payments were for

  • Consulting fees$150,98225%
  • Speaking & faculty fees$369,02660%
  • Travel & lodging$68,66111%
  • Food & beverage$23,8264%
  • Entertainment$1450%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
Regeneron Healthcare Solutions, Inc.260$215,993
Optinose US, Inc.163$104,907
GSK88$93,536
Aerin Medical Inc.62$48,835
Sanofi53$46,966
Stryker73$39,302
Insmed, Inc.20$11,448
Medtronic(2 entities)11$10,523
Genentech USA, Inc.7$10,012
Intersect ENT, Inc.21$8,928
F. Hoffmann-la Roche AG11$5,644
Smith+Nephew11$4,473
Genentech, Inc.7$3,940
Livanova USA, Inc.7$3,490
Inspire Medical Systems, Inc.49$3,216
Cochlear Americas2$310
KARL Storz Endoscopy-america3$256
AstraZeneca4$239
Lilly USA, LLC2$114
Johnson & Johnson(2 entities)2$109
Alk-abello, Inc3$107
ZOLL Respicardia, Inc.2$100
Neurent Medical Limited2$90
Paratek Pharmaceuticals, Inc.2$47
Acclarent, Inc1$26
Amgen1$16
Mylan Specialty L.p.1$14

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$612,640 in reported general payments places this provider in the 95th percentile of 1,021 otolaryngology providers in California.

See all otolaryngology providers in California →

Medicare billing

Part B allowed, 2024
$263,757
Medicare patients
438
Services billed
1,607

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Ipratropium Bromide84$2,520
Mometasone Furoate19$1,012
Ofloxacin34$930
Hydrocodone-AcetaminophenHydrocodone/Acetaminophen23$214
Cephalexin22$134

Paid to pharmacies, not to this prescriber.

Other otolaryngology in Roseville

See the full list for California →

Where these figures come from

Is this you, or does something look wrong? →